A final target of NUAK1 worth mentioning for its clinical relevance in Alzheimer’s disease is TAU (encoded by MAPT), independently found by two separate groups to be stabilised upon phosphorylation of S356 by NUAK1 [78,79]. This evidence concerns the gene NUAK1 and Alzheimer disease.